Does that explain why Guardion Health Sciences, Inc. (GHSI) shares have soared in the premarket?

Guardion Health Sciences, Inc. (GHSI)surged 23.08% to $0.388 in the premarket session following a specialty health sciences companyGHSI, announced that it had named Bret Scholtes, a culinary veteran for nearly a decade, as its President and Chief Executive Officer. He will also join its Board of Directors.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Mr. Scholtes served as CEO of Omega Protein since 2009, a global nutritional products company listed on the New York Stock Exchange until a strategic buyer successfully acquired it in late 2017.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Read More

Omega employed more than 1,100 employees in their branded and private label ingredient businesses. For his tenure at Omega, the company’s annual revenues increased by approximately 55%, the EBITDA increased by more than 70%, and its stock price increased by about 260%.
Scholtes introduced more than 40 new products and successfully expanded into several new markets by acquiring four companies with complementary product lines, adding approximately $125 million to revenues.Before joining Omega Capital, Mr. Scholtes was Vice President, Origination at GE Energy Financial Services, where he co-developed acquisitions with a value of more than $4 billion.A graduate of New York University and the University of Missouri and a Certified Public Accountant, Mr. Scholtes has held several accounting, development, and tax positions, including a residency at Price Waterhouse.

Related posts